參考文獻 |
1. Argiris, A., et al., Head and neck cancer. The Lancet, 2008. 371(9625): p. 1695-1709.
2. Bray, F., et al., Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2018. 68(6): p. 394-424.
3. Vineis, P., et al., Tobacco and cancer: recent epidemiological evidence. J Natl Cancer Inst, 2004. 96(2): p. 99-106.
4. William J. Blot, J.K.M., Deborah M. Winn, Donald F. Austin, Raymond S. Greenberg, Susan and L.B. Preston-Martin, Janet B. Schoenberg, Annette Stemhagen, and Joseph F. Fraumeni, Jr., Smoking and Drinking in Relation to Oral and Pharyngeal Cancer. Cancer research, 1988.
5. Chen, Y.J., et al., Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis. Cancer Sci, 2008. 99(8): p. 1507-14.
6. Silvia FRANCESCHI, F.L., Carlo LA VECCHIA, Ettore CONTI, Luigino DAL MASO, Luigi BARZAN and Renato TALAMINI, Comparison of the effect of smoking and alcohol drinking between oral and pharyngeal cancer. International Journal of Cancer, 1999. 83: p. 1-4.
7. Aimee R. Kreimer, G.M.C., Peter Boyle, and Silvia Franceschi, Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide A Systematic Review. American Association for Cancer Research, 2005.
8. Marur, S., et al., HPV-associated head and neck cancer: a virus-related cancer epidemic. The Lancet Oncology, 2010. 11(8): p. 781-789.
9. Marcel P. Copper, M.A.J., DDS; Jos J. P. Nauta, MSc; Boudewijn J. M. Braakhuis, PhD; and M.I.v.d.W. Nico de Vries, DDS; Gordon B. Snow, MD, Role of Genetic Factors in the Etiology of Squamous Cell Carcinoma of the Head and Neck. Arch Otolaryngol Head Neck Surg., 1995: p. 157-160.
10. Goldgar, D.E., et al., Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst, 1994. 86(21): p. 1600-8.
11. Foulkes WD, B.J., Sieh W, Black MJ, Shenouda G, Narod SA., Familial risks of squamous cellcarcinoma ofthehead and neck retrospectivecase-controlstudy. BMJ, 1996: p. 716-721.
12. Copper, M.P., et al., Role of genetic factors in the etiology of squamous cell carcinoma of the head and neck. Arch Otolaryngol Head Neck Surg, 1995. 121(2): p. 157-60.
13. Thoms, J. and R.G. Bristow, DNA repair targeting and radiotherapy: a focus on the therapeutic ratio. Semin Radiat Oncol, 2010. 20(4): p. 217-22.
14. Eriksson, D. and T. Stigbrand, Radiation-induced cell death mechanisms. Tumour Biol, 2010. 31(4): p. 363-72.
15. Renschler, M.F., The emerging role of reactive oxygen species in cancer therapy. Eur J Cancer, 2004. 40(13): p. 1934-40.
16. Jeong, H., et al., Radiation-induced immune responses: mechanisms and therapeutic perspectives. Blood Res, 2016. 51(3): p. 157-163.
17. Marur, S. and A.A. Forastiere, Head and neck cancer: changing epidemiology, diagnosis, and treatment. Mayo Clin Proc, 2008. 83(4): p. 489-501.
18. Department of Veterans Affairs Laryngeal Cancer Study, G., et al., Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med, 1991. 324(24): p. 1685-90.
19. Bonner, J.A., et al., Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med, 2006. 354(6): p. 567-78.
20. Bonner, J.A., et al., Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival. Lancet Oncol, 2010. 11(1): p. 21-8.
21. Higgins, G.S., et al., Drug radiotherapy combinations: review of previous failures and reasons for future optimism. Cancer Treat Rev, 2015. 41(2): p. 105-13.
22. Klein, J., J. Livergant, and J. Ringash, Health related quality of life in head and neck cancer treated with radiation therapy with or without chemotherapy: a systematic review. Oral Oncol, 2014. 50(4): p. 254-62.
23. Skvortsov, S., et al., Radioresistant head and neck squamous cell carcinoma cells: intracellular signaling, putative biomarkers for tumor recurrences and possible therapeutic targets. Radiother Oncol, 2011. 101(1): p. 177-82.
24. Siegel, R.L., et al., Colorectal cancer statistics, 2017. CA Cancer J Clin, 2017. 67(3): p. 177-193.
25. Jochem, C. and M. Leitzmann, Obesity and Colorectal Cancer. Recent Results Cancer Res, 2016. 208: p. 17-41.
26. Lynch, H.T. and A. de la Chapelle, Hereditary colorectal cancer. N Engl J Med, 2003. 348(10): p. 919-32.
27. Zou, Z., et al., Induction of reactive oxygen species: an emerging approach for cancer therapy. Apoptosis, 2017. 22(11): p. 1321-1335.
28. Tsuiko, O., et al., A speculative outlook on embryonic aneuploidy: Can molecular pathways be involved? Dev Biol, 2019. 447(1): p. 3-13.
29. Charitou, P. and B.M. Burgering, Forkhead box(O) in control of reactive oxygen species and genomic stability to ensure healthy lifespan. Antioxid Redox Signal, 2013. 19(12): p. 1400-19.
30. Assaily, W., et al., ROS-mediated p53 induction of Lpin1 regulates fatty acid oxidation in response to nutritional stress. Mol Cell, 2011. 44(3): p. 491-501.
31. Zhao, L., et al., Regulatory mechanisms and clinical perspectives of miRNA in tumor radiosensitivity. Carcinogenesis, 2012. 33(11): p. 2220-7.
32. Ambros, V., A hierarchy of regulatory genes controls a larva-to-adult developmental switch in C. elegans. Cell, 1989. 57: p. 49-57.
33. Rosalind C. Lee, R.L.F., Victor Ambros, The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell, 1993. 75: p. 843-854.
34. Zhao, T., et al., A complex system of small RNAs in the unicellular green alga Chlamydomonas reinhardtii. Genes Dev, 2007. 21(10): p. 1190-203.
35. Molnar, A., et al., miRNAs control gene expression in the single-cell alga Chlamydomonas reinhardtii. Nature, 2007. 447(7148): p. 1126-9.
36. Bartel, D.P., MicroRNAs: genomics, biogenesis, mechanism, and function. Cell, 2004. 116(2): p. 281-97.
37. Lee, Y., et al., MicroRNA genes are transcribed by RNA polymerase II. EMBO J, 2004. 23(20): p. 4051-60.
38. Lee, Y., et al., The nuclear RNase III Drosha initiates microRNA processing. Nature, 2003. 425(6956): p. 415-9.
39. Yi, R., et al., Exportin-5 mediates the nuclear export of pre-microRNAs and short hairpin RNAs. Genes Dev, 2003. 17(24): p. 3011-6.
40. Wang, Q. and J. Yu, MiR-129-5p suppresses gastric cancer cell invasion and proliferation by inhibiting COL1A1. Biochem Cell Biol, 2018. 96(1): p. 19-25.
41. Jin, K., et al., MiR-520b restrains cell growth by targeting HDAC4 in lung cancer. Thorac Cancer, 2018. 9(10): p. 1249-1254.
42. Liu, S.M., et al., miR-524-5p suppresses the growth of oncogenic BRAF melanoma by targeting BRAF and ERK2. Oncotarget, 2014. 5(19): p. 9444-59.
43. Zhang, P., et al., miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13. Nat Commun, 2014. 5: p. 5671.
44. Zheng, R., et al., miRNA-200c enhances radiosensitivity of esophageal cancer by cell cycle arrest and targeting P21. Biomed Pharmacother, 2017. 90: p. 517-523.
45. Qu, J.Q., et al., MiRNA-203 Reduces Nasopharyngeal Carcinoma Radioresistance by Targeting IL8/AKT Signaling. Mol Cancer Ther, 2015. 14(11): p. 2653-64.
46. Zhai, G., et al., miRNA-148b regulates radioresistance in non-small lung cancer cells via regulation of MutL homologue 1. Biosci Rep, 2016. 36(3).
47. Weber, J.A., et al., The microRNA spectrum in 12 body fluids. Clin Chem, 2010. 56(11): p. 1733-41.
48. Kosaka, N., H. Iguchi, and T. Ochiya, Circulating microRNA in body fluid: a new potential biomarker for cancer diagnosis and prognosis. Cancer Sci, 2010. 101(10): p. 2087-92.
49. Zen, K. and C.Y. Zhang, Circulating microRNAs: a novel class of biomarkers to diagnose and monitor human cancers. Med Res Rev, 2012. 32(2): p. 326-48.
50. Chen, X., et al., Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res, 2008. 18(10): p. 997-1006.
51. Ng, E.K., et al., Differential expression of microRNAs in plasma of patients with colorectal cancer: a potential marker for colorectal cancer screening. Gut, 2009. 58(10): p. 1375-81.
52. Park, N.J., et al., Salivary microRNA: discovery, characterization, and clinical utility for oral cancer detection. Clin Cancer Res, 2009. 15(17): p. 5473-7.
53. Li, A.L., et al., microRNA expression pattern as an ancillary prognostic signature for radiotherapy. J Transl Med, 2018. 16(1): p. 341.
54. Lin, Y. and Z. Lai, Reference gene selection for qPCR analysis during somatic embryogenesis in longan tree. Plant Science, 2010. 178(4): p. 359-365.
55. Jia, J., et al., LncRNA H19 interacted with miR-130a-3p and miR-17-5p to modify radio-resistance and chemo-sensitivity of cardiac carcinoma cells. Cancer Med, 2019. 8(4): p. 1604-1618.
56. Ha Thi, H.T., et al., MicroRNA-130a modulates a radiosensitivity of rectal cancer by targeting SOX4. Neoplasia, 2019. 21(9): p. 882-892.
57. Sharma, A., K. Singh, and A. Almasan, Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol, 2012. 920: p. 613-26.
58. Hoey, C., et al., miRNA-106a and prostate cancer radioresistance: a novel role for LITAF in ATM regulation. Mol Oncol, 2018. 12(8): p. 1324-1341.
59. Deng, P. and Y. Wu, Knockdown of miR-106a suppresses migration and invasion and enhances radiosensitivity of hepatocellular carcinoma cells by upregulating FBXW7. Int J Clin Exp Pathol, 2019. 12(4): p. 1184-1193.
60. Hou, W., et al., Inhibition of Beclin-1-Mediated Autophagy by MicroRNA-17-5p Enhanced the Radiosensitivity of Glioma Cells. Oncol Res, 2017. 25(1): p. 43-53.
61. Wu, S.Y., et al., MicroRNA-17-5p post-transcriptionally regulates p21 expression in irradiated betel quid chewing-related oral squamous cell carcinoma cells. Strahlenther Onkol, 2013. 189(8): p. 675-83.
62. Hu, Z., et al., miRNA-17 promotes nasopharyngeal carcinoma radioresistance by targeting PTEN/AKT. Int J Clin Exp Pathol, 2019. 12(1): p. 229-240.
63. Lynam-Lennon, N., et al., MicroRNA-17 is downregulated in esophageal adenocarcinoma cancer stem-like cells and promotes a radioresistant phenotype. Oncotarget, 2017. 8(7): p. 11400-11413.
64. Chen, W., et al., LINC00473/miR-374a-5p regulates esophageal squamous cell carcinoma via targeting SPIN1 to weaken the effect of radiotherapy. J Cell Biochem, 2019. 120(9): p. 14562-14572.
65. Huang, T., et al., MicroRNA-19b-3p regulates nasopharyngeal carcinoma radiosensitivity by targeting TNFAIP3/NF-kappaB axis. J Exp Clin Cancer Res, 2016. 35(1): p. 188.
66. Zhou, Y., et al., Let-7b overexpression leads to increased radiosensitivity of uveal melanoma cells. Melanoma Res, 2015. 25(2): p. 119-26.
67. Chang, L., et al., PI3K/Akt/mTOR pathway inhibitors enhance radiosensitivity in radioresistant prostate cancer cells through inducing apoptosis, reducing autophagy, suppressing NHEJ and HR repair pathways. Cell Death Dis, 2014. 5: p. e1437. |